Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
The analyst highlights Immunovant Inc’s (NASDAQ:IMVT) clinical results from the FcRn-targeting IMVT-1402, which showed 45% ...
Restaurant Chain Cava Is 'Positioned To Sustain Positive Transaction Growth,' Analyst Says
Experience robust growth with CAVA Group Q1 revenue surges 30.3% YoY, surpassing estimates. Wedbush maintaining an Outperform ...
Skyward Medical Transforms the Homecare Industry
Skyward Medical ensures all products are checked for quality assurance and carefully packaged for delivery. The company ...
Utility Bill Auditing Service To Sustain Budgets For The Unemployed Announced
Top-rated expense management platform Recession Resister announces utility bill auditing services designed to enhance budget ...
Toll Brothers Honored at the Best in Pennsylvania Living Awards
FT. WASHINGTON, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury ...
Velodrome Integrates with Metal L2 ‘The Banking Layer’
Strategic Integration to Boost Liquidity and Connectivity in the Optimism Superchain Ecosystem San Francisco, California, ...
Turbulent Outlook For American Airlines: Analysts Cut Forecasts As Competitive Pressures Mount
American Airlines lowers Q2 EPS guidance, analysts cut price target. Departure of Chief Commercial Officer announced.
ROSEN, A TOP RANKED LAW FIRM, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=24978 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for ...
Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
This proximity bias, discoverable through Recursion’s proprietary biological dataset, could have many downstream impacts on the community’s ability to make meaningful progress in our understanding and ...
Ulta Beauty Q1 Earnings Preview: Positive Foot Traffic Data May Offset Concerns Over Same-Store Sales
Ulta Beauty has beaten analysts' estimates for revenue and earnings per share for more than 10 straight quarters. Will the trend continue?
Snowflake's GenAI Initiatives Drive Investor Interest: Analyst Sees Strong Revenue Growth Ahead
Snowflake Inc (NYSE: SNOW) reiterated as Buy with $210 price target by Needham analyst Mike Cikos due to GenAI initiatives and new CEO's direction.
Dick's Sporting Goods Raised Outlook After Strong Q1 Earnings, But Analyst Is Watching For Inventory Shrink Commentary
Goldman Sachs analyst Kate McShane reiterated a Buy rating on the shares of Dick's Sporting Goods. According to the analyst, the stock gained due to the earnings beat and higher 2024 guidance.